Literature DB >> 16769832

Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma.

Yaniv Barkana1, Sarah Anis, Jeffrey Liebmann, Celso Tello, Robert Ritch.   

Abstract

OBJECTIVE: To determine whether intraocular pressure (IOP) monitoring outside of normal office hours adds clinically useful information.
METHODS: We reviewed the records of all patients with glaucoma who were admitted for 24-hour IOP monitoring during 3 years. Applanation IOP was recorded in the sitting position from 7 am until midnight and in the supine position at 6 am.
RESULTS: Thirty-two patients (22 women and 10 men) were enrolled (mean +/- SD age, 67.3 +/- 12.1 years). Mean +/- SD 24-hour IOP was 13.0 +/- 2.2 mm Hg. Mean +/- SD peak 24-hour IOP (16.8 +/- 3.2 mm Hg) was significantly higher than peak office IOP (14.7 +/- 3.2 mm Hg) (P<.001). Peak IOP was recorded outside of office hours in at least 1 eye in 22 patients (69%). Mean IOP fluctuation during 24-hour monitoring (6.9 +/- 2.9 mm Hg) was significantly greater than that during office hours (3.8 +/- 2.3 mm Hg) (P<.001). Peak 24-hour IOP was higher than the peak IOP noted during previous office visits in 40 eyes (62%). Results of 24-hour IOP monitoring led to immediate treatment change in 23 eyes (36%).
CONCLUSIONS: In glaucoma patients with advanced disease or progression that are disproportionate to known IOP measurements, 24-hour monitoring of IOP may reveal a greater role for pressure-related risk for glaucoma progression than previously suspected and may alter treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769832     DOI: 10.1001/archopht.124.6.793

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  63 in total

1.  Diurnal versus office-hour intraocular pressure fluctuation in primary adult onset glaucoma.

Authors:  Tarun Arora; Shveta Jindal Bali; Vishal Arora; Meenakshi Wadhwani; Anita Panda; Tanuj Dada
Journal:  J Optom       Date:  2014-06-16

2.  [Presentation of software for collation of inpatient diurnal pressure profiles in glaucoma patients].

Authors:  S Christmann; C Leisser; N Schrage
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

3.  Correlation between intraocular pressure obtained with water drinking test versus modified diurnal tension curve measurement in pseudoexfoliation glaucoma.

Authors:  Penpe Gül Firat; Seyhan Dikci; İlknur Tuncer Firat; Soner Demirel; Murat Firat; Emrah Öztürk; Zarife Ekici Gök
Journal:  Int Ophthalmol       Date:  2021-04-20       Impact factor: 2.031

4.  Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Robert N Weinreb
Journal:  Clin Exp Ophthalmol       Date:  2015-08-16       Impact factor: 4.207

5.  Effect of hevin deletion in mice and characterization in trabecular meshwork.

Authors:  Min Hyung Kang; Dong-Jin Oh; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

6.  Why Do People (Still) Go Blind from Glaucoma?

Authors:  Remo Susanna; Carlos Gustavo De Moraes; George A Cioffi; Robert Ritch
Journal:  Transl Vis Sci Technol       Date:  2015-03-09       Impact factor: 3.283

7.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

8.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

9.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30

10.  The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma.

Authors:  Andrzej Stankiewicz; Joanna Wierzbowska; Anna Siemiatkowska; Beata Fuksinska; Jacek Robaszkiewicz; Arkadiusz Zegadlo; Rita Ehrlich; Brent Siesky; Alon Harris
Journal:  Br J Ophthalmol       Date:  2010-06-16       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.